Endocrine disrupting chemicals (EDCs), which are synthetic or natural endocrine disrupters, are known to interact with the human estrogen receptors (hERs). [1] [2] [3] [4] For the screening of EDC candidates, several in vitro assays, including a radioisotopelabeled estrogen-ER competitive binding assay, 4 an enzymelinked receptor binding assay (ELRA), 5 a surface plasmon resonance (SPR)-based ligand-receptor binding assay, 6 ,7 a yeast estrogen screening assay (YES), 8 and other reporter gene assays, are currently available in this field.
Introduction
Endocrine disrupting chemicals (EDCs), which are synthetic or natural endocrine disrupters, are known to interact with the human estrogen receptors (hERs). [1] [2] [3] [4] For the screening of EDC candidates, several in vitro assays, including a radioisotopelabeled estrogen-ER competitive binding assay, 4 an enzymelinked receptor binding assay (ELRA), 5 a surface plasmon resonance (SPR)-based ligand-receptor binding assay, 6 ,7 a yeast estrogen screening assay (YES), 8 and other reporter gene assays, are currently available in this field.
In spite of the current concentrated studies, each method still requires improvements for making a practically feasible EDC screening assay as to 1) detecting all classes of estrogen candidates, 2) measuring a large number of potentially contaminated samples in a short time (large sample throughput), 3) providing an on-site analysis to identify contaminated rivers and waste waters of industries, 9 and 4) providing a sensitive analysis which can substitute, for example, a DNA-binding assay using a radioisotope, and supply a low detection limit. 10 The estrogen dependence of hERα-ERE (estrogen response element) binding was demonstrated in earlier in vitro studies, such as SPR kinetic studies, 6, 7 and a polyacrylamide gel mobility shift assay focused on the pre-incubation temperature of the samples. 11 The estrogen-dependent hERα-ERE binding is interpreted as implying that the binding of estrogen to its receptor induces conformational changes that not only modulate the interactions of hERα with transcriptional factors, but also directly affect the association and dissociation rate constants of the hERα-ERE binding. 6, 12 The estrogen-dependent results of the SPR and polyacrylamide gel mobility shift assays led us to consider a new EDC screening assay combining the advantages of each method, i.e., an SPR-like rapid determination scheme during a restricted time using an arrayed device, and having an EDC screening scheme based on the quantitative binding of hERα on a three-dimensional (3D) ERE-immobilized gel support. As a suitable gel substance, agarose gel was carefully examined for our purpose because it provides a three-dimensional medium for the immobilization of a DNA probe. 13 Through this 3D immobilization, we can expect an increase in the immobilization capacity by higher than 100 times, compared to the conventional 2D glass surface immobilization. [13] [14] [15] [16] In this paper, we report on a new approach for analyzing the hormonal activity of estrogens by visualizing the event of hERα-ERE binding using the yellow fluorescence protein-fused human estrogen receptor α (YFP-hERα).
The strong fluorescence intensity from the YFP-hERα, which is estrogendependently extracted into the gel medium, affords the identification and quantification of the hormonal activities of estrogens. Thus, we discriminated the hormonal activities of five commercially available estrogens (17β-estradiol (E2; a steroid), ethynylestradiol (EE2; a steroid), diethylstilbestrol (DES; a biphenyl ethylene), 4-hydroxy tamoxifen (OHT; a triphenyl ethylene), and clomiphene (Clo; a triphenyl ethylene) (Fig. 1)) . We also discuss their responses based on the chemical structures of each estrogen. To our knowledge, this study constitutes the first feasible analysis scheme of EDCs using a YFP-fused hERα for signal induction, and an arrayed gel medium for a high sample throughput and sensitivity.
Experimental

Equipment and reagents
A 16-well micro glass slide was purchased from Nalge Nunc International (Naperville, IL, USA). Agarose (gel strength 2200 g/cm 2 ), NaIO4, and NaCNBH3, were obtained from Wako Chemical Co. (Tokyo, Japan).
A 17β-estradiol (E2), ethynylestradiol (EE2), diethylstilbestrol (DES), 4-hydroxy tamoxifen (OHT), clomiphene (Clo), and EDTA-free protease inhibitor cocktail was obtained from Sigma Co. (St. Louis, MO, USA). The hERα cDNA plasmid was purchased from American Type Culture Collection (ATCC, VA, USA). The YFP cDNA plasmid was kindly provided by R. Y. Tsien, University of California (CA, USA). The fluorescence intensity of YFP-hERα on glass slides was determined with a fluorescence plate reader (Twinkle LB970, PerkinElmer™, Boston, MA, USA) and a tungsten-halogen lamp for excitation at 490 nm and a 530 nm cut-off polarization filter for reading.
The estrogen-hERα incubation, hERα-ERE binding, and glass slide washing were done in a TBST buffer (1% Tween 20, 0.15 M NaCl, 0.05 M Tris-H2SO4, pH 7.5).
Two different single-stranded DNA sequences were purchased from Nissinbo Co. (Chiba, Japan), one with 5′-biotinylated (see below for the specific sequence); the other was its complementary single strand. The sequence was 5′-A G C T C T T T G A T C A G G T C A C T G TGACCTGAACTTACTCCCCCCGAGCAAGTTCAGGTCA CAGTGACCTGATCAAAG-3′ (a 75 bp oligonucleotide derived from vitellogenin A2 gene of Xenopus laevis response promoter). It contains a palindromic inverted repeat element containing the sequence AGGTCA spaced by 3 bp, derived from the vitellogenin A2 gene (Vit. A2) promoter (boldface of the sequence). The purchased single strands were hybridized in a 4 × SSC buffer (0.2% SDS, 0.6 M NaCl, 0.06 M sodium citrate, pH 7.0) at 75˚C for 2 h. The biotinylated fluorescein termed "fluorescein-biotin" was purchased from Molecular Probes (Eugene, Oregon, USA) and was used for quantification of the immobilized avidin on the agarose gel layer.
Other chemicals were all of analytical reagent grade. All aqueous solutions were prepared with a Milli-Q grade (>18.2 MΩ resistance) water system (Millipore Co., Bedford, MA, USA).
Preparation of DNA probe-modified glass slides
A glass-bottom slide was adapted in this study because it has a low background fluorescence compared to a plastic-bottom plate. An amine modification of the surface of the bare glass slide was made according to a previous method. 17 The glass slides were immersed in a 10% NaOH solution and subsequently washed with water, and then in a 1% HCl solution, washed again with water and methanol, and finally placed in an oven at 60˚C for 30 min. A solution of 5% 3-aminopropyl triethoxy silane dissolved in acetone was then added into each well of the glass slides. The excess solution was decanted off and the glass slides were washed again with ethanol and allowed to stand for 30 min at 60˚C. This direct modification on a glass surface is known to produce a glass stationary phase containing 80 -90 mmoles of NH2/g-support in the case of the glass beads used in chromatography. 17 A 150 µL of pre-heated 1% agarose sol was injected on each well of a 75˚C pre-heated glass slide, and the bottom side was immediately cooled down by placing it on a cold tissue paper for 5 s; the upper sol solutions were then removed. Extremely uniform and thin gel layers (thickness: ∼0.17 mm) were found on the glass slide. After gelling of the agarose sol, the slides were covered and placed in a humid box for 2 h for stabilization of the gel. The immobilization of a DNA probe in agarose gel was performed according to a previously described method. 13 For the activation of agarose gel, a 0.02 M NaIO4 solution was added to each well of the gel-mounted glass slide, which was then incubated for 30 min at room temperature, washed in distilled water, and dried. Subsequently, a 50 µL avidin solution (1.2 mg/ml avidin, 0.1 M bicarbonate buffer, pH 10) was added to each well of the activated slide. It was kept at room temperature for 2 h and in a refrigerator at 4˚C overnight. The glass slide was then washed with a TBST buffer three times, and finally added by a 50 µL biotinylated DNA probe (ERE, Vit. A2) solution in a TBST buffer with 1% skim milk, of which the final probe concentration was 3.8 × 10 -7 M, and stocked at 4˚C overnight. The immobilized DNA probe in the agarose gel layer was authenticated by using ethidium bromide (EtBr). The prepared glass slides were kept at 4˚C and used up within one week.
Construction of plasmid (HisTag-YFP-hERα), fusion protein expression, and purification
For making the DNA plasmid, a coding region of hERα (C-F domain) was amplified by a polymerase chain reaction (PCR) from the hERα plasmid using the following primers: 5′ primer GGACATCGATAAGGAGACTCGCTACTGTG, and 3′ primer GGACGGATCCTTAGACTGTGGCAGGGAAACC.
The fragment was flanked with unique ClaI (5′) and BamHI (3′) sites. A DNA fragment of YFP was amplified by PCR from the YFP plasmid using the following primers: 5′ primer GGACCATATGGTGAGCAAGGGCGAG, and 3′ primer TGACATCGATCTTGTACAGCTCGTCCAT; unique NdeI (5′) and ClaI (3′) sites were introduced, respectively. These two PCR fragments were ligated with the ClaI site to form a fusion construct. The construct was inserted into NdeI/BamHI sites of the expression vector pET15b, just downstream of a stretch coding for a hexahistidine tag. The product was sequenced to ensure fidelity. E. Coli BL21 (DE3)pLysS were transformed with the plasmid, and grown in 250 mL of Luria broth (LB) at 37˚C up to an A600 of 0.7 -0.8. Then, the expression of the fusion protein was induced by adding 2.0 × 10 -4 M isopropyl β-D-thiogalactoside (IPTG). Four hours after induction, the cultured bacteria were precipitated by centrifugation (15 min, × 1500g). The precipitate was resuspended by ∼5 mL of a TBST buffer containing an aliquot of EDTA-free protease inhibitor cocktail (Sigma, St. Louis, USA), and disrupted by an ultrasonic treatment in an AT200-Bioruptor sonicator (Cosmo Bio, Seraing, Belgium). 18 The E. Coli extracts were again centrifuged by a Beckman centrifuge (15 min, × 3000g, Palo Alto, CA, USA) for removing lipids and other solid components of E. Coli. The YFP-hERα in the supernatant was purified to homogeneity using a Ni 2+ -affinity column. The fusion protein was then eluted from the column with 0.05 M, 0.10 M, and 0.25 M solutions of imidazole, and finally dialyzed to a Tris-H2SO4 buffer (0.05 M, pH 7.5) for one day by changing the buffer several times. 6 The concentrations of the total protein in the dialyzed solution and the fusion protein (YFP-hERα) in it were determined by the absorbance at 280 nm and at 514 nm, respectively. The total molecular weight of the YFP-hERα was assured by Coomassie Brilliant Blue (CBB) staining and Western blotting using a mouse anti-hERα antibody. The YFPhERα solution was then stocked in an ice bath for its continuous use, and used up in one week. All of the subsequent experiments were performed with the same protein stock solution obtained from a Ni 2+ -affinity column.
Quantification of the immobilized avidin on a glass slide
A precise avidin quantification method in an aqueous solution was introduced by Gruber et al. 19, 20 The method was applied in our experiment for the quantification of the immobilized avidin on an agarose gel surface. The quantification principle of the method is based on the severe quenching of "fluorescein-biotin" when it makes a bind with the biotin-binding sites of an avidin molecule on the gel, compared to the free condition. The fluorescein-biotin stock solution was diluted stepwise from 1.6 × 10 -8 M to 1.6 × 10 -13 M. Sets of the diluted solutions were simultaneously injected into the wells of the avidin-immobilized glass slide by a multi-pipette. After 30 min of incubation for the avidin-biotin binding reaction at room temperature, the upper solution was decanted off, and the glass slide was washed immediately by a TBST buffer. The fluorescence intensities of each well of the glass slide were then measured using a fluorescence plate reader with a reflection mode (Fig. 3(A) ).
Determination of the optimal YFP-hERα protein concentration for glass slide assay
For choosing the optimum concentration of the fusion protein (YFP-hERα) for a glass slide assay, a series of determinations with controlled concentrations of fusion protein were performed with ERE-immobilized glass slides. The protein solutions were prepared by dilution from a stock solution containing 7.1 × 10 -7 M fusion protein with a TBST buffer; the final concentrations were given at the X-axis of Fig. 3 (B) . A fixed concentration of E2 was then added to the set of solutions (100 µl each) to make the final E2 concentration of 1.0 × 10 -8 M and incubated for 3 h at 4˚C, and then extensively incubated at 37˚C for 30 min before the measurement. The set of prepared protein solutions, 100 µl each, was simultaneously injected into the DNA-modified glass slide. Ten minutes after injection, the upper solutions of each well were decanted off and the slide was washed with a TBST buffer to remove any non-specific adsorbent on each well. The fluorescence intensity of each well was then determined by a fluorescence plate reader with a reflection mode.
Glass slide assay and data analysis
A stock solution including 7.1 × 10 -7 M of YFP-hERα was diluted to a concentration of 8.9 × 10 -9 M by a TBST buffer. Different concentrations of estrogens ranging from 1.0 × 10 -7 to 1.0 × 10 -15 M (final concentration) were added to each aliquot (100 µl) of hERα solutions, and incubated for 3 h at 4˚C. The series of sample solutions was extensively incubated at 37˚C for 30 min. After the hERα-ERE binding step for ∼10 min, the upper solutions of each well were decanted off and washed out with a TBST buffer to remove any non-specific adsorbent on the well. The YFP-hERα, which was estrogen-dependently extracted into the gel medium on the glass slide, was quantified by determining the fluorescence intensities of each well on the glass slide with a fluorescence plate reader with a reflection mode. For a correction of the fluorescence intensity among the glass slides, a standard control, which was a vehiclesupplemented 8.9 × 10 -9 M YFP-hERα solution, was simultaneously determined with other samples. In the estrogenfree condition, it does not show an increase in the fluorescence intensity from specific hERα-ERE binding (Fig. 2 (B), (C) ).
Results and Discussion
Quantification of the avidin immobilized on an agarose layer of a glass slide
For the quantification of avidin immobilized on a gel layer of a glass slide, one previous quantification method was modified for our purpose. 19, 20 Until the four binding sites of avidin on a gel layer of the glass slide were completely filled with the injected biotinylated fluorescein, the fluorescence intensity on the surface was suppressed due to a quenching effect of the 501 ANALYTICAL SCIENCES APRIL 2003, VOL. 19 Fig. 2 Picture of the glass slide (A) and its schematic diagram for the signal development (B) and (C). Under a 37˚C pre-incubation condition, the E2-free YFP-hERα shows no specific hERα-ERE binding ability (B). On the other hand, the E2-activated YFP-hERα is extracted into the DNA probe (ERE)-immobilized thin agarose layer during the hERα-ERE binding step for 10 min (C). After the hERα-ERE binding, the fluorescence intensity from the extracted fusion protein, YFP-hERα, can directly be determined by a fluorescence plate reader.
bound biotinylated fluorescein to avidin (Fig. 3 (A) ). After the four biotin-binding sites of avidin were filled, the fluorescence intensity was sharply enhanced. This may have been due to surplus biotinylated fluorescein being adsorbed nonspecifically on the gel while suffering no quenching effect.
The characteristic titration curve of biotinylated fluorescein was similar to those of previous studies. 19, 20 The titration curves from biotinylated fluorescein showed a characteristic inflection point (arrow; Fig. 3 (A) ). Also the concentration of biotinylated fluorescein at the extrapolated point was 2.5 × 10 -9 M, which was obtained from the intersection between the curve fit of seven experimental points on the left and a linear fit of three experimental points on the right of the inflection point. From the experimental data and the volume injected on the well, the density of the valid biotin-binding sites on the well was estimated, i.e., ∼24.4 ± 4.2 × 10 -14 mol/well. The evaluated value is consistent with the density level of the DNA probe reported in previous studies. 13, 14 
Optimization of the fusion protein (YFP-hERα) concentrations for the EDC screening assay
The choice of the optimal concentration of the fusion protein for the glass slide assay is important to obtain a high fluorescence signal.
An extremely high YFP-hERα concentration increases any non-specific adsorption on the glass slide, while a too low YFP-hERα concentration can cause a weak fluorescence intensity. 21 In order to evaluate the optimal YFP-hERα concentration, a series of experiments were performed by changing the concentrations of the fusion protein at a fixed E2 concentration, where the final concentration of E2 was 1.0 × 10 -8 M. The background fluorescence intensity caused by non-specific binding was greatly increased at concentrations of the fusion protein higher than 8.9 × 10 -9 M (Fig. 3 (B) ). 3.6 × 10 -8 M of YFP-hERα, which was the highest concentration available in this experiment for completing a series of experiments, caused a large increase in the background fluorescence intensity in the E2-free glass slide assay (Fig.  3(B) ). Therefore, the signal-to-background ratio was best at 8.9 × 10 -9 M of the fusion protein concentration, at which subsequent experiments were performed. The concentration used in this experiment was in the range recommended by a previous paper as being the optimum concentration for a highaffinity interaction of E2-induced hERα with ERE. 21 
Determination of hERα-ERE binding induced by estrogens, E2, EE2, DES, OHT, and Clo
The hERα-ERE binding is influenced by the pre-incubation temperature 11 and estrogen, 6, 7, 12, 21 besides the concentration of the estrogen receptor. 21 The effect of the pre-incubation temperature on an estrogensupplemented hERα-ERE binding was examined with the optimized receptor concentration, 8.9 × 10 -9 M. The results showed a temperature-dependent profile, in which a test with 37˚C pre-incubation exhibited about a two-times higher fluorescence intensity than with 4˚C pre-incubation in the range of the E2 concentration from 1.0 × 10 -12 to 1.0 × 10 -10 M (data not shown). This result is consistant with previous studies, in which hERα was subjected to a temperature-cooperative conformational change in the presence of estrogen, which caused their high affinity for ERE. 11, 21 The effects of various estrogens on the interaction of YFPhERα with ERE were explored next. Based on the hERα-ERE binding mechanism illustrated on Figs . In the case that the hERα-ERE binding assay was performed at 8.9 × 10 -9 M of YFP-hERα (asterisk marked on (B)), the nonspecific fluorescence was decreased down to the background noise level, while the signal fluorescence was still preserved (n = 3, ave ± std).
measurements. In the control experiments, a bare glass slide, itself, and a glass slide assay without YFP-hERα did not show a specific estrogen-dependent hERα-ERE interaction, and the overall fluorescence intensities were sustained in half of the baseline intensities of the other experimental data, in which the fluorescence intensities of the two remained up to ∼650 (data not shown). The average fluorescence intensity and standard deviation among the bare glass slides were 611 ± 34 (n = 3, ave ± std). Similarly, without the immobilization of ERE, the glass slide assay did not show estrogen-dependent dose-response curves. On the other hand, with the immobilized ERE, the glass slide showed clear estrogen-dependent dose-response curves (Fig. 4) .
The tested ligands (DES, E2, and EE2) are synthetic or natural sex hormones, and are known as pure agonists, 6 which are responsible for the development and maintenance of the female sex characteristics. E2 and EE2 are structurally members of steroid hormones, 22 and are very similar to each other in their chemical structures (Fig. 1) . Actually, the dose-response curves of the two nearly overlapped (Fig. 4) . The other pure agonist, DES, was more potent. The extrapolated points of the dose response curves of DES, E2, and EE2 on the bottom lines were 0.3 × 10 , and 1.3 × 10 -13 M, respectively (Fig. 4) . On the other hand, OHT and Clo, known as partial agonists, 6 are members of the group of triphenyl ethylenes. 22 They have similar chemical structures to each other (Fig. 1) . However, OHT is more analogous than Clo to the pure agonist DES (a bisphenyl ethylene) in its functional groups and side chain, which might cause favorable conformational changes of hERα for binding ERE, and thus results in a higher affinity for ERE and lower detection limit than that of Clo.
This corresponds to previous study conclusions, in which different estrogens induced different conformational changes of hERα dimers, the ligand binding of which dramatically affected the binding constants of the hERα interaction with its ERE. 6, 7 In summary, the determined effects of estrogens on the interaction of YFP-hERα with ERE were as follows in decreasing order:
The order is similar to those of other EDC assays, such as an hERα-estrogen competitive binding assay, an SPR assay, a CAT reporter gene assay, and a gel mobility shift assay. 4, 6, 7, 9, 11, 23 Sensitivity and detection limit of the glass slide-based EDC screening assay
For a sensitivity determination of the glass slide assay, we took advantage of the high immobilization capacity of an agarose gel, because the gel has a 100-times or higher immobilization capacity when compared to conventional 2D glass support-based assays. [13] [14] [15] The increased immobilization capacity contributed to the higher sensitivity of the glass slide assay, and the detection limit became comparable to those of other assays, e.g. as low as to ∼10 -13 M for E2, which is similar to those of the conventional assays, such as the luciferase reporter gene assay based on the MCF-7 cell line and the E screen assay. 9, 10 
Conclusion
An EDC screening assay was devised with a new array-type DNA glass slide. The analytical method is based on the estrogen-dependent hERα-ERE binding scheme of SPR kinetic assays 6, 7 with an arrayed glass slide for a high sample throughput and a three-dimensional immobilization of ERE to agarose gel for a sensitive determination. Each hormonal activity of DES, E2, EE2, OHT, and Clo was monitored with the optimized concentration of the fusion protein (YFP-hERα) (8.9 × 10 -9 M) and the pre-incubation condition at 37˚C. The glassslide assay allowed a sensitive determination with a detection limit of ∼10 -13 M level for E2. The present method fulfills the requirements for an effective EDC screening, such as 1) a high sample throughput, 2) a compact device size allowing a small sample volume, and 3) an integrated sensitivity and low detection limit through a 3D DNA probe immobilization on agarose gel. Other fluorescence proteins, such as green and cyan fluorescence proteins, besides YFP, can likewise be applicable for this study. Adapted 16-well glass slides are available as 16-well strips, easy to be assembled with a 96-well frame to enlarge the sample throughput.
The present characteristic screening assay will become competitive alternative to the conventional EDC screening assays.
